TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Go back to TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $26.80 | |||
| Open | $0.32 | 52 Week Low | $23.00 | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $0.00 | |||
| Volume | 20 | |||||
